Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2026-08-18 14:45:24 ET · period of report 2026-08-18 · accession 0001834423-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 14:45 | 2026-08-18 | ABCL | Montalbano John S. | Dir | P - Purchase | $11.03 | +10.0K | 251.0K | +4% | +$110.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-08-18 | P | A | 10,000 | $11.03 | 251,000 | D | — | — |